Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Ocular Immunology and Inflammation|August 11, 2018
Ocular Nocardiosis: A Case ReportReinhard Angermann, Martin Stattin, Claus Zehetner
Acta Ophthalmologica|September 30, 2020
Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucomaTeresa Rauchegger, Reinhard Angermann, Peter Willeit, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|December 4, 2018
Triamcinolone in small-gauge vitrectomy for epiretinal membrane peelingReinhard Angermann, Claus Zehetner, Patrick Sidoroff, et al.
Journal of Ophthalmology|March 10, 2020
Effect of Timing on Visual Outcomes in Fovea-Involving Retinal Detachments Verified by SD-OCTReinhard Angermann, Nikolaos E Bechrakis, Teresa Rauchegger, et al.
BMC Ophthalmology|September 19, 2022
Long-term persistence with aflibercept therapy among treatment-naïve patients with exudative age-related macular degeneration in a universal health care system: a retrospective studyReinhard Angermann, Alexander Franchi, Katharina Frede, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 10, 2019
Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverageReinhard Angermann, Teresa Rauchegger, Yvonne Nowosielski, et al.
Klinische Monatsblatter Fur Augenheilkunde|November 27, 2019
[Patient Mobility and Journey Distance as Risk Factors for Severe Visual Impairment: Real-Life Data Analysis of Treatment-naïve Patients with nAMD under Intravitreal Aflibercept Therapy]Teresa Rauchegger, Reinhard Angermann, Anja Meusburger, et al.
Journal of Ophthalmology|December 27, 2021
Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular DegenerationAnna Lena Huber, Reinhard Angermann, Yvonne Nowosielski, et al.
BMJ Open Ophthalmology|October 4, 2021
Effects of COVID-19 protective measures on the ophthalmological patient examination with an emphasis on gender-specific differencesTeresa Rauchegger, Antonia Osl, Yvonne Nowosielski, et al.
International Journal of Retina and Vitreous|June 24, 2026
Real-world outcomes after switching to faricimab in previously treated neovascular age-related macular degeneration: longitudinal outcomes up to 24 monthsDaniel Egger, Florian Amesbauer, Hamza Mohamed, et al.
Pageof 3